Patients with IBD had a lower proportion of NCR+ ILC3 compared to HCs (54.55 vs. 91.10% of total ILCs, p < 0.001; 0.11 vs. 0.33% of total CD45+ cells, p < 0.001). This evidence concerns the gene PTPRC and inflammatory bowel disease.